Company · CIK 1863127
Tyra Biosciences, Inc.
| CIK | 1863127 (SEC EDGAR) |
|---|---|
| Industry (SIC) | 2834 — Pharmaceutical Preparations |
| Incorporated in | DE |
| Business address | CA |
| Listed | TYRA (Nasdaq) |
| First annual or quarterly report | 2021-11-03 |
Offerings
5 registrations| Registration | Label and status | First filed | Last event | Filings |
|---|---|---|---|---|
| 333-298911 | 2026-09-14 | 2026-09-15 | 2 | |
| 333-287086 | 2025-05-08 | 2026-08-04 | 3 | |
| 333-278068 | 2024-03-19 | 2024-04-22 | 2 | |
| 333-267712 | 2022-10-03 | 2022-10-13 | 2 | |
| 333-258970 | 2021-08-20 | 2021-09-15 | 5 |
Filings
15| Filed | Filing | Registration | Accession |
|---|---|---|---|
| 2026-09-15 | 424B5Shelf takedown | 333-298911 | 0001193125-26-390947 |
| 2026-09-14 | S-3ASRShelf registered | 333-298911 | 0001193125-26-389752 |
| 2026-08-04 | 424B5Shelf takedown | 333-287086 | 0001193125-26-333055 |
| 2025-05-16 | EFFECTDeclared effective | 333-287086 | 9999999995-25-001644 |
| 2025-05-08 | S-3Shelf registered | 333-287086 | 0001193125-25-116008 |
| 2024-04-22 | EFFECTDeclared effective | 333-278068 | 9999999995-24-001069 |
| 2024-03-19 | S-3Shelf registered | 333-278068 | 0001193125-24-071361 |
| 2022-10-13 | EFFECTDeclared effective | 333-267712 | 9999999995-22-003041 |
| 2022-10-03 | S-3Shelf registered | 333-267712 | 0001193125-22-256638 |
| 2021-09-15 | 424B4Final prospectus | 333-258970 | 0001193125-21-273963 |
| 2021-09-14 | EFFECTDeclared effective | 333-258970 | 9999999995-21-003510 |
| 2021-09-14 | S-1/AAmendment | 333-258970 | 0001193125-21-272111 |
| 2021-09-09 | S-1/AAmendment | 333-258970 | 0001193125-21-268272 |
| 2021-08-20 | S-1Registration filed | 333-258970 | 0001193125-21-252729 |
| 2021-05-28 | DRSDraft made public | 377-04947 | 0000950123-21-007433 |